Cronos Group Inc.
corporate_fare Company Profile
Cronos Group Inc. (NASDAQ:CRON) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 11 items for CRON at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 11 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for CRON spans 8-K, 10-Q, 10-K.
Recent high-impact activity:
- Cronos Jumps Premarket as Q3 Revenue Tops Consensus by 20%
- Cronos Q3 2026: Revenue Up 75% to $63.5M, Adjusted EBITDA $17.1M, Buybacks Cut Share Count
- Cronos Closes €57.5M CanAdelaar Acquisition, Establishes Dutch Cannabis Platform
- Cronos Closes €57.5M CanAdelaar Deal, Takes Europe's Largest Adult-Use Cannabis Platform
- Cronos Group Swings to Q2 Profit on 58% Revenue Surge; New Anti-Dumping Probe Looms
Financial Snapshot
Short Interest & Short Volume
4.94 days to coverFINRA reported short interest of 4,151,803 shares in CRON as of the October 30, 2026 settlement, a 4.9% increase from the prior period — about 4.9 days to cover at its recent average daily volume. On November 20, 2026, 34.6% of CRON volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.